leisure time -WSS

leisure time

author：knowledge 2025-09-03 03:40:22 - browse：36

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

WSS

AI can’t replace a physician’s gut feeling

How dance can help nurses traumatized by Covid

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Sanofi seeks simpler, safer CRISPR sickle cell cure

Biden declares emergency in flood

Listen: Wegovy in the brain & pivotal Alzheimer's data

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Activists slam private health insurers over coverage restrictions

Pandemic and All Hazards Preparedness Act needs lean update

As demand for Covid shots wanes, Moderna seeks its next success

Medicare to cover more brain scans for Alzheimer’s patients

Activists slam private health insurers over coverage restrictions

AI can’t replace a physician’s gut feeling

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA approves RSV monoclonal antibody for infants, toddlers

Bright Health sells Medicare Advantage business to Molina

Eisai exec who led development of Alzheimer’s drug to retire

focus

WHO calls for emergency meeting on new China virus, as cases spread

Teachers share how revamped forgiveness program helped with their student loans

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

At Orexo, a ‘turning point’ for everything but digital health

STAT Virtual Event: The State of Biosimilars: What to Watch

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Wikipedia

leisure time

explore

focus